Know Cancer

or
forgot password

A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma


N/A
N/A
N/A
Open (Enrolling)
Both
Hodgkin's Disease

Thank you

Trial Information

A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma


Inclusion Criteria:



- Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment
of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69).

- English speaking

Exclusion Criteria:

- None

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

To evaluate the prevalence of late medical complications among HL survivors

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

David Straus, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

05-041

NCT ID:

NCT00598728

Start Date:

May 2005

Completion Date:

May 2013

Related Keywords:

  • Hodgkin's Disease
  • Survivors
  • Quality of Life
  • Hodgkin Disease
  • Lymphoma

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021